| Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later |
19 |
| Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration |
9 |
| Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update |
9 |
| The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data |
9 |
| A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis |
6 |
| Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA |
5 |
| Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders |
5 |
| The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future |
5 |
| Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon |
5 |
| Bayesian Networks: A New Approach to Predict Therapeutic Range Achievement of Initial Cyclosporine Blood Concentration After Pediatric Hematopoietic Stem Cell Transplantation |
5 |
| Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies |
4 |
| Suvorexant (Belsomra((R)) Tablets and 20mg): Japanese Drug-Use Results Survey |
4 |
| Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects |
4 |
| The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study |
4 |
| Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis |
3 |
| Octreotide Use in Neonates: A Case Series |
3 |
| Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies |
3 |
| 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes |
3 |
| Intranasal Therapy to Stop Status Epilepticus in Prehospital Settings |
3 |
| Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial |
3 |
| Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study |
3 |
| Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate |
3 |
| A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment |
3 |
| A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation |
2 |
| Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK |
2 |
| Ulcerative Colitis: Shifting Sands |
2 |
| Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication |
2 |
| Isavuconazole Kinetic Exploration for Clinical Practice |
2 |
| Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change |
2 |
| Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting |
2 |
| Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects |
2 |
| The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A |
2 |
| Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice |
2 |
| Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment |
2 |
| Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with Darunavir |
2 |
| Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers |
2 |
| The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients |
2 |
| Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis |
2 |
| Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules |
1 |
| Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia |
1 |
| S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study |
1 |
| Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers |
1 |
| Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life? |
1 |
| Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly |
1 |
| Assessment of Taste and Grittiness of Riomet((R)) ER Strawberry, Riomet((R)) ER Grape, Riomet((R)) Cherry, and Metformin Immediate-Release Tablets in Healthy Subjects |
1 |
| Sealing Effects on the Storage Stability of the Cyanide Antidotal Candidate, Dimethyl Trisulfide |
1 |
| Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age |
1 |
| Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder |
1 |
| Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation |
1 |
| Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab |
1 |
